Molecular mechanisms associated with breast cancer based on integrated gene expression profiling by bioinformatics analysis

被引:13
作者
Wu, Di [1 ]
Han, Bing [1 ]
Guo, Liang [2 ]
Fan, Zhimin [1 ]
机构
[1] Jilin Univ, Hosp 1, Dept Breast Surg, Xinmin St 71, Changchun 130021, Peoples R China
[2] Jilin Univ, Hosp 1, Dept Pathol, Changchun 130021, Peoples R China
关键词
Breast cancer; CCNG1; ADAMTS1; molecular mechanisms; G2/M ARREST; CYCLIN G1; ADAMTS-1; P53; MIGRATION; SURVIVAL; CELLS;
D O I
10.3109/01443615.2015.1127902
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In this study, we aimed to gain more insights into the underlying molecular mechanisms responsible for breast cancer (BC) progression. Three gene expression profiles of human BC were integrated and used to screen the differentially expressed genes (DEGs) between healthy breast samples and BC samples. Protein-protein interaction (PPI) network of DEGs was constructed by mapping DEGs into the Search Tool for the Retrieval of Interacting Genes (STRING) database; then the subnetworks of PPI were constructed with plug-in, MCODE and DEGs in Subnetwork 1 were analysed based on Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway database (http://www.genome.jp/kegg/). In addition, co-expression network of DEGs was established using the Cytoscape. Totalally 931 DEGs were selected, including 340 up-regulated genes and 591 down-regulated genes. KEGG pathway analysis for DEGs in Subnetwork 1 showed that the pathogenesis of BC was associated with cell cycle, oocyte meiosis, progesterone-mediated oocyte maturation and p53 signalling pathways. Meanwhile, the most significant-related DEGs were found by co-expression network analysis of DEGs. In conclusion, CCNG1 might be involved in the progression of BC via inhibiting cell proliferation, and ADAMTS1 might play a crucial role in BC development through the regulation of angiogenesis.
引用
收藏
页码:615 / 621
页数:7
相关论文
共 44 条
[21]  
Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18
[22]   Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas [J].
Kuo, Wen-Hung ;
Chang, Yao-Yin ;
Lai, Liang-Chuan ;
Tsai, Mong-Hsun ;
Hsiao, Chuhsing Kate ;
Chang, King-Jen ;
Chuang, Eric Y. .
PLOS ONE, 2012, 7 (09)
[23]   P53 and breast cancer, an update [J].
Lacroix, Marc ;
Toillon, Robert-Alain ;
Leclercq, Guy .
ENDOCRINE-RELATED CANCER, 2006, 13 (02) :293-325
[24]   ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165 [J].
Luque, A ;
Carpizo, DR ;
Iruela-Arispe, ML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) :23656-23665
[25]   Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials [J].
Mackey, John R. ;
Kerbel, Robert S. ;
Gelmon, Karen A. ;
McLeod, Deanna M. ;
Chia, Stephen K. ;
Rayson, Daniel ;
Verma, Sunil ;
Collins, Loretta L. ;
Paterson, Alexander H. G. ;
Robidoux, Andre ;
Pritchard, Kathleen I. .
CANCER TREATMENT REVIEWS, 2012, 38 (06) :673-688
[26]  
Masui T, 2001, CLIN CANCER RES, V7, P3437
[27]  
Merdad A, 2014, ANTICANCER RES, V34, P1355
[28]   An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival [J].
Miller, LD ;
Smeds, J ;
George, J ;
Vega, VB ;
Vergara, L ;
Ploner, A ;
Pawitan, Y ;
Hall, P ;
Klaar, S ;
Liu, ET ;
Bergh, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (38) :13550-13555
[29]   Wnt pathway and breast cancer [J].
Mohinta, Sonia ;
Wu, Hailong ;
Chaurasia, Priyasri ;
Watabe, Kounosuke .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :4020-4033
[30]  
NUGENT JHA, 1991, J CELL SCI, V99, P669